ABSTRACT-We sought to determine (a) if early lactate clearance is associated with improved survival in emergency department patients with severe sepsis and (b) the concordance between central venous oxygen saturation (ScvO 2 ) optimization and lactate clearance during early sepsis resuscitation. Within a multicenter shock research network that uses quantitative resuscitation for severe sepsis, we analyzed prospectively collected registries of consecutive emergency department patients diagnosed with severe sepsis at three urban hospitals. Inclusion criteria are as follows: (a) age older than 17 years, (b) two or more systemic inflammation criteria, (c) systolic blood pressure 90 mmHg or less after fluid challenge or initial lactate of 4mmol/L or greater, and (d ) initial and repeat lactate measurement within 6 h of resuscitation initiation. We stratified patients into two groups defined a priori based on previously published data: (a) lactate clearanceVrepeat lactate decrease by 10% or greater from initial (or both initial and repeat levels e2.0 mmol/L), and (b) lactate non-clearanceVrepeat lactate decrease by less than 10% from initial. The primary outcome was in-hospital mortality. Among 166 patients, lactate non-clearance occurred in 15 (9%) of 166. Mortality was 60% for lactate nonclearance versus 19% for lactate clearance, P G 0.001. On multivariate analysis, lactate non-clearance was an independent predictor of death (odds ratio, 4.9 [confidence interval, 1.5Y15.9]). We found discordance between ScvO 2 optimization and lactate clearance; 79% of lactate non-clearance had concomitant ScvO 2 of 70% or greater. In this multicenter cohort of sepsis patients, failing to clear lactate during resuscitation carried a high risk of death, and ScvO 2 optimization did not reliably exclude lactate non-clearance. These data provide rationale for a clinical trial of lactate clearance as a distinct end point of early sepsis resuscitation.
INTRODUCTION
Severe sepsis is the most common cause of death in critically ill patients (1) . The effectiveness of early resuscitation is an important determinant of sepsis survival (2) . Specifically, early quantitative resuscitation, the use of a structured set of cardiovascular interventions targeting predefined hemodynamic end points, can have a profound effect on hospital mortality (3) . Currently, international consensus treatment guidelines recommend a quantitative resuscitation strategy that includes targeting central venous oxygen saturation (ScvO 2 ) of 70% or greater in the first 6 h of severe sepsis therapy (4) . However, the optimal end points of sepsis resuscitation remain controversial (5, 6) .
Serum lactate elevation is an important marker of impaired tissue perfusion in patients with sepsis and is often elevated even in the absence of arterial hypotension (7) . Numerous studies show that a single early lactate measurement has important prognostic significance and predicts mortality in populations of patients with infection (8, 9) . A small number of studies have previously reported that serial measurements of lactate have potential prognostic value during conventional sepsis management (10Y12); however, it is not known if lactate clearance is associated with survival in the context of medical centers that have adopted and routinely perform aggressive quantitative resuscitation for severe sepsis. In addition, it is not known if lactate clearance is important independent of other recommended quantitative resuscitation end points, specifically ScvO 2 .
The objectives of this study were to determine (a) if early lactate clearance is associated with improved survival in emergency department (ED) patients with severe sepsis and (b) the concordance between ScvO 2 optimization and lactate clearance during early sepsis resuscitation.
METHODS

Setting and study design
We analyzed prospectively collected registries of consecutive ED patients diagnosed with severe sepsis at three urban hospitals. The three hospitals are part of a multicenter research collaborative (Emergency Medicine Shock Research Network) (13) , where each institution uses ED-based protocolY directed quantitative resuscitation for patients with severe sepsis (14Y16). The registries were compiled between 2004 and 2007 and were approved 35 by the institutional review board at each institution. Of the 166 subjects in this report, the subjects from one center (n = 110) were a subset of a total of 1,352 patients in two prior publications (8, 15) , and the remainder were previously unpublished. Neither of the previous reports was focused on serial lactate measurement in sepsis.
Participants
The inclusion criteria were based on consensus definitions for severe sepsis (17) and included (a) age older than 17 years, (b) suspected infection, (c) two or more criteria of the systemic inflammatory response syndrome, (d) either a systolic blood pressure (SBP) less than 90 mmHg after 20 mL/kg or greater i.v. fluid or an initial serum lactate 4 mmol/L or greater, (e) initial and repeat lactate measurement within 6 h of resuscitation initiation, and (e) intensive care unit admission.
Interventions
Consistent with international treatment guidelines for patients with severe sepsis and evidence of tissue hypoperfusion (hypotension after i.v. fluids or initial lactate Q4 mmol/L) (4), each participating center uses a similar quantitative resuscitation algorithm targeting normalization of ScvO 2 (Q70%) in the ED (14Y16). Figure 1 displays elements of the resuscitation protocol common to each center. The registry used in this study was designed to measure the achievement of each goal within the protocol as a dichotomous variable (yes/no) at specified time intervals (i.e., 6 h). We did not accrue specific data on the use of red blood cell transfusion, dobutamine use, or time of antibiotic administration. ScvO 2 was measured using a central venous catheter inserted into the superior vena cava via internal jugular or subclavian venous access that provides continuous measurement of ScvO 2 via reflection spectrophotometry (Edwards Lifesciences, Irvine, Calif). Treatment algorithms at each center mandate the measurement of an initial serum lactate in the ED. Obtaining a repeat lactate level is not a mandated practice at any of the centers and is obtained at the discretion of the treating clinician. All lactate assessments were obtained from venous blood samples and were measured according to local institutional standard methods using a central laboratory at two centers and a point-of-care analyzer (Abbott Point of Care, Abbott Park, Ill) at the third center.
Data collection
Using a standardized data abstraction template, we queried each of the three registries and collected the following data: demographics, suspected source of infection, vital signs, initial and repeat serum lactate concentrations, laboratory values for organ failure assessment, and outcome information. Illness severity was defined using the presence of individual organ system failures as assessed by the worst recorded values for each organ system while in the ED: cardiovascular = initial SBP less than 90 mmHg; pulmonary = new oxygen requirement or PaO 2 /FIO 2 less than 300 or SpO 2 /FIO 2 less than 221; renal = serum creatinine more than 2.0 mg/dL; hepatic = serum bilirubin greater than 2.0 mg/dL; hematologic = platelets less than 100,000/2L or international normalized ratio more than 1.5 sec (18); and calculation of the Sequential Organ Failure Assessment (SOFA) score (19) as modified by Vincent et al. (20) .
Data analysis
To determine the association between lactate clearance and mortality, we stratified patients into two groups defined a priori based on previously published data (12): (a) lactate clearanceVrepeat lactate decrease by 10% or greater from initial (or both initial and repeat levels e2.0 mmol/L), and (b) lactate non-clearanceVrepeat lactate decrease by less than 10% from initial. The primary outcome was in-hospital mortality.
We wanted to determine if ScvO 2 optimization during resuscitation could reliably exclude lactate non-clearance; therefore, we evaluated the concordance between achievement of ScvO 2 optimization (Q70%) and lactate clearance goals (Q10%) over the first 6 h of resuscitation using a 2 Â 2 table.
Statistical analysis
We analyzed the difference in proportions of death between lactate clearance and non-clearance groups using the binomial test and the associated 95% confidence intervals (CIs) and P values. All other variables between lactate clearance versus lactate non-clearance groups and between survivors versus nonsurvivors were compared using the binomial test or Student t test when appropriate. We performed multivariate logistic regression analysis using candidate variables that were significantly different (P G 0.05) between survivors and nonsurvivors on bivariate analysis, with in-hospital mortality as the dependent variable. We used SigmaStat (v. 3.5; Systat, Chicago, Ill) for all analyses.
Sample size estimate
We estimated the necessary sample size based on the following assumptions: (a) a predicted mortality rate of 25% overall (based on previously published experience with quantitative resuscitation for severe sepsis at the three centers) (14Y16); (b) an event (death) per variable ratio of 10:1 necessary for multivariate modeling (21, 22) ; and (c) the multivariate model would need to, at a minimum, include the following covariates that have previously been shown to differentiate sepsis survivors from nonsurvivors: arterial hypotension (23), failure to achieve ScvO 2 70% or greater (2), and lactate non-clearance (12) . To accrue the necessary 30 cases of mortality to test these three covariates in a multivariate model, we estimated that a minimum of 120 total cases would be necessary.
RESULTS
Characteristics of study cohort
There were 166 subjects who met inclusion criteria. The overall mortality rate was 23% (38/166). Figure 2 displays the Kaplan-Meier curves for survival fractions over time. The curves diverge significantly by log-rank test (P = 0.003). There was no significant difference in achievement of Characteristics of study subjects with lactate clearance (910%) and nonclearance (G10%) over the first 6 h (n = 166). SOFA, Sequential Organ Failure Assessment; ED, Emergency Department.
FIG. 2.
Kaplan-Meier survival curves. This graph depicts survival curves over time for lactate clearance (lactate decrease by Q10%) and lactate nonclearance (lactate decrease G10%) groups. The curves diverge significantly by log-rank test (P = 0.003). Table 4 compares survivors with nonsurvivors. On bivariate analysis, there were four factors that were significantly different (P G 0.05) between survivors and nonsurvivors: (a) initial cardiovascular organ failure (initial SBP G90 mmHg), (b) persistent hypotension (SBP G90 mmHg) despite intravenous fluids, (c) maximum ScvO 2 less than 70%, and (d ) lactate non-clearance. Table 5 shows the results for the multivariate logistic regression model. Because ScvO 2 had a significant association with mortality in the bivariate analysis, we limited the regression model to include only subjects in whom ScvO 2 was measured continuously (n = 148). We omitted one of the two hypotension-related covariates (initial SBP G90 mmHg) from inclusion in the model on the grounds that it could be collinear with the persistent hypotension covariate. Lactate nonclearance was found to be a strong independent predictor of inhospital mortality (odds ratio, 4.9; 95% CI, 1.5Y15.9).
Survivors versus nonsurvivors
DISCUSSION
In this multicenter sample of ED patients with severe sepsis, we found that early lactate clearance was a strong independent predictor of in-hospital death. In addition, optimization of ScvO 2 during resuscitation was not sufficient to exclude lactate non-clearance. This is the first study to evaluate the impact of lactate clearance on survival in the presence of a protocol-directed quantitative resuscitation algorithm for the treatment of patients with severe sepsis, and to date, this is the largest study evaluating lactate clearance in patients with sepsis (10Y12).
The cause of an elevated serum lactate in patients with sepsis can be multifactorial. Although lactate elevation may result from acute tissue hypoperfusion and anaerobic metabolism (24), other possible causes may include (a) sepsisinduced impairment of pyruvate-dehydrogenase enzyme activity (25) , (b) increased lactate production via catecholamine-driven pathways (26Y28), and (c) decreased lactate clearance due to hepatic dysfunction (29, 30) . However, regardless of etiology of an elevated serum lactate, lactate elevation in sepsis has been consistently linked to increased mortality (7Y12). Although initial reports of lactate clearance in sepsis were published more than 15 years ago (10), evaluating lactate trends during resuscitation is not yet part of the current consensus recommendations for sepsis management (4) and is not routinely performed in practice. While optimizing ScvO 2 could in theory be a single comprehensive monitor of the systemic balance between global oxygen delivery and consumption in sepsis patients with circulatory shock (2, 4) , our data show that assessment of lactate clearance is important as a predictor of mortality independent of achievement of ScvO 2 goals and that tracking ScvO 2 does not reliably reflect the effectiveness of lactate clearance during resuscitation. Therefore, these data suggest that serial lactate measurement may provide unique and important information on resuscitation effectiveness.
We acknowledge important limitations in interpreting these results. First, this is a nonexperimental observational study and as such can detect only the association between lactate clearance and mortality but cannot establish cause and effect. Second, because performing serial lactate measurement in patients with sepsis is not a mandatory practice in our centers and measurements are performed at the discretion of the clinician, this could potentially represent a source of selection bias. Third, there was a relatively low incidence (9%) of lactate non-clearance in this cohort. This may be attributable to highly aggressive resuscitation practices in the EDs of the participating centers (14Y16). In the only other ED-based study of lactate clearance in severe sepsis, Nguyen et al. (12) reported a lactate non-clearance rate of 29% using the same cutoffs for clearance and non-clearance used in this study. One potential explanation for this disparity is the aggressiveness of crystalloid resuscitation administered in the first 6 h, 4.4 L Factors associated with increased mortality on bivariate analysis were evaluated with in-hospital mortality as the dependent variable (n = 148) Logistic regression model was limited to subjects for which ScvO 2 was measured continuously (148/166). lactate non-clearance = less than 10% decrease in repeat lactate value; hypotension = SBP G90 mmHg after a 20-mL/kg i.v. fluid bolus.
compared with 3.3 L in the Nguyen et al. study. Therefore, an additional limitation is that the results of the current study may be applicable only to centers that have implemented quantitative resuscitation for sepsis in the ED setting. It is possible that there were deviations from the quantitative resuscitation protocols; however, this study was implemented as an effectiveness trial, so we did not specifically catalogue potential deviations. We identified and enrolled our patients prospectively in the ED, and it is possible that some of the patients diagnosed with sepsis in the ED may have been misclassified and had other etiologies accounting for their presentation. Fourth, our registry did not account for underlying comorbidities that may have had an association with outcome and should be addressed in future studies. Finally, we used all-cause in-hospital mortality as our outcome; it is possible that patients may have died from nonYsepsis-related causes.
As severe sepsis carries a persistently high mortality rate and the adequacy of resuscitation is a critical determinant of survival (2, 3) , the identification of the optimal markers for restoration of effective tissue perfusion and the ideal end points for a resuscitation algorithm are a high priority for sepsis research. Although ScvO 2 optimization has been shown to be important in one clinical trial (2) and was an independent predictor of mortality in the current study, lactate clearance may prove to be an equivalent resuscitation end point for patients with severe sepsis. This hypothesis warrants further investigation in future clinical trials (31) .
CONCLUSION
Early lactate clearance seems to be an important determinant of survival in patients with severe sepsis. In this multicenter study, lactate non-clearance during the resuscitation phase of therapy was a strong independent predictor of in-hospital death. In the context of quantitative resuscitation, assessment of lactate clearance provides unique information on resuscitation effectiveness. ScvO 2 optimization does not reliably exclude lactate non-clearance. These data support the rationale for a clinical trial of lactate clearance as a distinct end point of early sepsis resuscitation.
